search
LDL cholesterol
Trends
- 1Single CRISPR treatment halves bad cholesterol for a year▼One CRISPR treatment cut “bad” cholesterol in half for a full year
A one-time CRISPR-based treatment has reportedly cut LDL, the so-called bad cholesterol, roughly in half with the effect lasting a full year, according to a report carried by ScienceDaily. If confirmed in larger trials, a single infusion could replace daily statins for some patients at risk of heart disease. The finding is drawing attention as a potential milestone for gene-editing therapies targeting common chronic conditions.